Autologous Natural Killer T Cells Infusion for the Treatment of Cancer

NCT01801852 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Glioma
Hepatocellular Cancer
Squamous Cell Lung Cancer
Pancreatic Cancer
Colon Cancer
Prostate Cancer

Interventions

BIOLOGICAL: NKT cells

Sponsor

Chinese PLA General Hospital

Collaborators

[object Object]